nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—HTR4—adrenal cortex—adrenal gland cancer	0.0898	0.159	CbGeAlD
Ondansetron—HTR4—pituitary gland—adrenal gland cancer	0.0725	0.129	CbGeAlD
Ondansetron—HTR4—adrenal gland—adrenal gland cancer	0.0648	0.115	CbGeAlD
Ondansetron—CYP1A2—urine—adrenal gland cancer	0.0472	0.0837	CbGeAlD
Ondansetron—CYP2C9—urine—adrenal gland cancer	0.0448	0.0795	CbGeAlD
Ondansetron—CYP2E1—urine—adrenal gland cancer	0.0425	0.0753	CbGeAlD
Ondansetron—CYP3A4—urine—adrenal gland cancer	0.0342	0.0606	CbGeAlD
Ondansetron—CYP2D6—urine—adrenal gland cancer	0.0336	0.0596	CbGeAlD
Ondansetron—SLC47A1—adrenal cortex—adrenal gland cancer	0.0238	0.0422	CbGeAlD
Ondansetron—SLC47A1—gonad—adrenal gland cancer	0.0197	0.035	CbGeAlD
Ondansetron—SLC47A1—pituitary gland—adrenal gland cancer	0.0192	0.0341	CbGeAlD
Ondansetron—SLC47A1—adrenal gland—adrenal gland cancer	0.0172	0.0305	CbGeAlD
Ondansetron—KCNH2—cardiac atrium—adrenal gland cancer	0.0121	0.0214	CbGeAlD
Ondansetron—HTR1A—adrenal gland—adrenal gland cancer	0.0118	0.021	CbGeAlD
Ondansetron—KCNH2—pituitary gland—adrenal gland cancer	0.0118	0.0209	CbGeAlD
Ondansetron—KCNH2—adrenal gland—adrenal gland cancer	0.0105	0.0187	CbGeAlD
Ondansetron—CYP2E1—adrenal gland—adrenal gland cancer	0.00812	0.0144	CbGeAlD
Ondansetron—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00178	0.00408	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00178	0.00408	CbGpPWpGaD
Ondansetron—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00178	0.00408	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00175	0.00401	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00172	0.00394	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00168	0.00385	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00168	0.00385	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00166	0.00381	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00164	0.00375	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00162	0.0037	CbGpPWpGaD
Ondansetron—HTR1B—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00161	0.0037	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—POMC—adrenal gland cancer	0.00158	0.00361	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00157	0.0036	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00148	0.0034	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00148	0.0034	CbGpPWpGaD
Ondansetron—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00144	0.00331	CbGpPWpGaD
Ondansetron—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00144	0.0033	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00144	0.00329	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00143	0.00327	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00143	0.00327	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00138	0.00317	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00137	0.00314	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00136	0.00311	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00133	0.00304	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00132	0.00303	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00131	0.003	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0013	0.00298	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00129	0.00295	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00128	0.00293	CbGpPWpGaD
Ondansetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00126	0.0029	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00126	0.00288	CbGpPWpGaD
Ondansetron—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00125	0.00287	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00125	0.00287	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00123	0.00282	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00123	0.00282	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TSHR—adrenal gland cancer	0.00122	0.0028	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—GNAS—adrenal gland cancer	0.0012	0.00275	CbGpPWpGaD
Ondansetron—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00116	0.00265	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MEN1—adrenal gland cancer	0.00115	0.00263	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00114	0.00261	CbGpPWpGaD
Ondansetron—KCNH2—Neuronal System—BRAF—adrenal gland cancer	0.00114	0.00261	CbGpPWpGaD
Ondansetron—HTR1B—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00109	0.00249	CbGpPWpGaD
Ondansetron—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00107	0.00246	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00107	0.00244	CbGpPWpGaD
Ondansetron—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	0.00106	0.00243	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00106	0.00242	CbGpPWpGaD
Ondansetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00103	0.00235	CbGpPWpGaD
Ondansetron—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00102	0.00233	CbGpPWpGaD
Ondansetron—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000989	0.00227	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—GNAS—adrenal gland cancer	0.000978	0.00224	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000968	0.00222	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00096	0.0022	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GNRHR—adrenal gland cancer	0.000954	0.00219	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00095	0.00218	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—SDHB—adrenal gland cancer	0.000947	0.00217	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00094	0.00216	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—POMC—adrenal gland cancer	0.00089	0.00204	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000887	0.00203	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—PRKACA—adrenal gland cancer	0.000875	0.00201	CbGpPWpGaD
Ondansetron—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000868	0.00199	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000864	0.00198	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000863	0.00198	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.000863	0.00198	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000854	0.00196	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000842	0.00193	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000838	0.00192	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000834	0.00191	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000828	0.0019	CbGpPWpGaD
Ondansetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000827	0.00189	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00082	0.00188	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000812	0.00186	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—POMC—adrenal gland cancer	0.000809	0.00185	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000783	0.00179	CbGpPWpGaD
Ondansetron—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.000767	0.00176	CbGpPWpGaD
Ondansetron—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.000766	0.00176	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000763	0.00175	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000761	0.00174	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000749	0.00172	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000749	0.00172	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000745	0.00171	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CDC42—adrenal gland cancer	0.000742	0.0017	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000737	0.00169	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000736	0.00169	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000727	0.00167	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000724	0.00166	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IGF2—adrenal gland cancer	0.000716	0.00164	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—GNAS—adrenal gland cancer	0.000709	0.00163	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000692	0.00159	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.000686	0.00157	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000685	0.00157	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000676	0.00155	CbGpPWpGaD
Ondansetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00067	0.00154	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000659	0.00151	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—POMC—adrenal gland cancer	0.000658	0.00151	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000657	0.00151	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000635	0.00146	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000619	0.00142	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.00061	0.0014	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.00061	0.0014	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TERT—adrenal gland cancer	0.000596	0.00137	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.000581	0.00133	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000578	0.00133	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000572	0.00131	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000553	0.00127	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000546	0.00125	CbGpPWpGaD
Ondansetron—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000544	0.00125	CbGpPWpGaD
Ondansetron—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.00054	0.00124	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000525	0.0012	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000523	0.0012	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000521	0.00119	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—BAD—adrenal gland cancer	0.000518	0.00119	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00051	0.00117	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TSHR—adrenal gland cancer	0.00051	0.00117	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000505	0.00116	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000502	0.00115	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000501	0.00115	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000488	0.00112	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000487	0.00112	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000483	0.00111	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000479	0.0011	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—POMC—adrenal gland cancer	0.000478	0.00109	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—BRAF—adrenal gland cancer	0.000472	0.00108	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000472	0.00108	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000463	0.00106	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000461	0.00106	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.000461	0.00106	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000457	0.00105	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MED12—adrenal gland cancer	0.000455	0.00104	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00045	0.00103	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000445	0.00102	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000443	0.00102	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.000442	0.00101	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.000442	0.00101	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.000441	0.00101	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.000441	0.00101	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00044	0.00101	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000435	0.000998	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000423	0.000969	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000421	0.000965	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.000412	0.000945	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.0004	0.000917	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000398	0.000913	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000388	0.00089	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000382	0.000876	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00038	0.000871	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000372	0.000853	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000366	0.000838	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000365	0.000837	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000356	0.000816	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000341	0.000781	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000338	0.000774	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	0.000332	0.000761	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.00033	0.000756	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.000329	0.000754	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000328	0.000753	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000325	0.000744	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000323	0.00074	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000318	0.00073	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000314	0.000719	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000314	0.000719	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000311	0.000713	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000311	0.000713	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	0.00031	0.000711	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000299	0.000685	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000298	0.000683	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000296	0.000679	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000289	0.000663	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000283	0.00065	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000279	0.000639	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000274	0.000628	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—EGFR—adrenal gland cancer	0.00027	0.000619	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GNAS—adrenal gland cancer	0.000269	0.000617	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.000266	0.000609	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.000266	0.000609	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	0.000264	0.000605	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000264	0.000605	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000262	0.0006	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000257	0.00059	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000255	0.000585	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000249	0.00057	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.00024	0.000551	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.00024	0.00055	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000236	0.000542	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000234	0.000536	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000232	0.000532	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000228	0.000522	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TP53—adrenal gland cancer	0.000227	0.00052	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000226	0.000518	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00022	0.000505	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	0.00022	0.000503	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000216	0.000496	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000207	0.000475	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000205	0.00047	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000205	0.00047	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.0002	0.000457	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000198	0.000454	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000197	0.000452	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000195	0.000447	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.000194	0.000446	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000191	0.000438	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000191	0.000438	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000191	0.000438	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000191	0.000437	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.00019	0.000435	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—POMC—adrenal gland cancer	0.000181	0.000415	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000177	0.000406	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000176	0.000404	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000174	0.000399	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000171	0.000391	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000169	0.000388	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000169	0.000386	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000165	0.000379	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000165	0.000378	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000153	0.000351	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.000152	0.000348	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.00015	0.000344	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000146	0.000334	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000145	0.000331	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	0.000144	0.000331	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000142	0.000326	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000141	0.000324	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000138	0.000317	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000137	0.000314	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000136	0.000311	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000135	0.000308	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000131	0.000301	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.000131	0.0003	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000126	0.000288	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.000117	0.000269	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	0.000115	0.000264	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000113	0.000259	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000112	0.000256	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000108	0.000249	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	0.000105	0.00024	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	0.000104	0.000239	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	9.96e-05	0.000228	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	9.47e-05	0.000217	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—adrenal gland cancer	9.31e-05	0.000213	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—adrenal gland cancer	9.23e-05	0.000212	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GNAS—adrenal gland cancer	9.04e-05	0.000207	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	8.87e-05	0.000203	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	8.6e-05	0.000197	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	8.36e-05	0.000192	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—adrenal gland cancer	7.89e-05	0.000181	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	7.43e-05	0.00017	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	7.36e-05	0.000169	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	7.22e-05	0.000165	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	6.29e-05	0.000144	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—adrenal gland cancer	6.09e-05	0.00014	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.86e-05	0.000111	CbGpPWpGaD
